Navigation Links
Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign

Dana-Farber Campaign is Largest Hospital Fundraising Effort in New England


WATERTOWN, Mass., Oct. 2 /PRNewswire/ -- Corey McPherson Nash (CMN), the branding and design studio, is proud to recognize the successful design and development of the case statement supporting Dana-Farber Cancer Institute's capital campaign. CMN developed the case statement, along with additional branding and design work, to support Dana-Farber's efforts to secure the financial resources necessary to accelerate the pace of discovery, speed the application of scientific knowledge, and expand the Institute's ability to provide its signature total patient care.

"Our $1 billion goal marks the most ambitious capital campaign in the Institute's history," said Susan Paresky, Senior Vice President for Development at Dana-Farber Cancer Institute. "We have already seen a tremendous positive response to the campaign."

Dana-Farber Cancer Institute officially launched the campaign, "Mission Possible: The Dana-Farber Campaign to Conquer Cancer," in January 2007. "The success of the capital campaign for Dana-Farber Cancer Institute is extremely important to the Institute and to Corey McPherson Nash," said Michael McPherson, creative director and partner, CMN. "We worked closely with Dana- Farber to ensure that the visual components of this campaign reflect and reinforce the Institute's mission of saving lives. The results of this campaign will ensure that Dana-Farber continues the rigorous research and treatment to make this possible."

For more than 20 years, CMN has helped clients to enhance their communications with thoughtful branding and design. Visit the CMN website at

About Corey McPherson Nash

Corey McPherson Nash, a national branding and design studio, helps organizations achieve measurable brand equity across a wide variety of print and interactive communications. Their longstanding commitment to cause related issues has made it the branding firm of choice for a wide range of leading cultural and educational institutions. Widely recognized for its thoughtful design and strategic insights into the critical task of strategic brand iteration and creative development, CMN clients include OXFAM, The Huntington Theater Company, The Pan Mass Challenge, The Dana Farber Cancer Institute, the Museum of Science, Boston, and Children's Hospital Boston. Visit CMN online at

SOURCE Corey McPherson Nash
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bioengineering production strains - Microbia develops new methods
2. Vical Biotech and NIH jointly develops HIV vaccine
3. Kirin Develops a Cure for Bird Flu
4. Starpharma Develops New Gel (Vivagel) To Prevent HIV Transmission
5. Georgia Institute of Technology develops doppler Vein finder
6. Hungary Develops New Bird Flu Vaccine
7. Dutch chemical group Akzo Nobel Develops A New Bird Flu Vaccine
8. ICAR develops bird flu vaccine
9. Samsung Develops Device to Measure Body Fat
10. India Develops Test for Diagnosis of Deadly Livestock Disease
11. Mouth Cancer Develops In Two Different Ways
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: